Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Mounjaro
Mounjaro
FDA adds aspiration warning to Ozempic, Mounjaro and other GLP-1 labels
Beckers Hospital Review
Wed, 11/6/24 - 08:01 pm
FDA
warnings
aspiration
Ozempic
Wegovy
Saxenda
Mounjaro
Novo Nordisk
Eli Lilly
Lilly shares fall as obesity drug sales miss forecasts
BioPharma Dive
Wed, 10/30/24 - 11:52 am
Eli Lilly
earnings
obesity
Zepbound
Mounjaro
Lilly to launch its obesity drug in Denmark, Novo Nordisk's home market
Reuters
Thu, 10/24/24 - 09:53 am
Eli Lilly
Mounjaro
Novo Nordisk
Denmark
obesity
FDA, facing pressure, to review position on Zepbound, Mounjaro shortage
BioPharma Dive
Mon, 10/14/24 - 11:17 pm
Eli Lilly
drug shortages
Zebound
Mounjaro
FDA
Lilly's weight-loss drug removed from FDA's shortage list
Reuters
Thu, 10/3/24 - 10:06 am
Eli Lilly
FDA
drug shortages
Mounjaro
Weight Loss From GLP-1 Drugs Not As Robust In Real-World Settings
Forbes
Wed, 10/2/24 - 11:20 am
weight loss
obesity
GLP-1 agonist
Ozempic
Wegovy
Novo Nordisk
Zepbound
Mounjaro
Eli Lilly
Patients sue over alleged stomach paralysis linked to Ozempic, Mounjaro
Beckers Hospital Review
Tue, 10/1/24 - 10:45 am
legal
Novo Nordisk
Eli Lilly
Ozempic
Mounjaro
gastroparesis
Inside the GLP-1 'price war'
Beckers Hospital Review
Tue, 09/24/24 - 11:52 am
GLP-1 agonists
obesity
weight loss
Eli Lilly
Novo Nordisk
Ozempic
Wegovy
Zepbound
Mounjaro
drug pricing
New research could ease concerns over suicide risk of obesity drugs
BioPharma Dive
Tue, 09/3/24 - 05:58 pm
obesity
suicide
GLP-1
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Mounjaro
Zepbound
Lilly’s tirzepatide cuts diabetes risk, study data show
BioPharma Dive
Tue, 08/20/24 - 11:54 am
Eli Lilly
tirzepatide
Mounjaro
Zepbound
type 2 diabetes
diabetes
clinical trials
FDA says all doses of Lilly's weight-loss and diabetes drug are now available
Reuters
Sun, 08/4/24 - 06:44 pm
Eli Lilly
FDA
Zepbound
Mounjaro
drug shortages
Patients on weight-loss drugs should inform doctor before surgery, EU regulator says
Reuters
Fri, 07/12/24 - 11:16 am
EMA
Novo Nordisk
Ozempic
Wegovy
Eli Lilly
Mounjaro
Zepbound
surgery
Lilly’s Mounjaro Helps Patients Lose More Weight Than Novo’s Ozempic: Study
BioSpace
Tue, 07/9/24 - 11:51 am
Eli Lilly
Mounjaro
Novo Nordisk
Ozempic
weight loss
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro
Reuters
Mon, 07/1/24 - 09:52 pm
Eli Lilly
Mounjaro
India
obesity
Lilly files more lawsuits to curb sales of counterfeit Mounjaro
Reuters
Thu, 06/20/24 - 11:26 am
Eli Lilly
drug counterfeiting
Mounjaro
Eli Lilly exec says seeing out of pocket payments for obesity drug in US
Reuters
Mon, 06/10/24 - 06:06 pm
Eli Lilly
Zepbound
Mounjaro
patients
obesity
diabetes
Weight-loss drug forecasts jump to $150 billion as supply grows
Reuters
Wed, 05/29/24 - 11:48 am
Eli Lilly
Novo Nordisk
weight loss
Wegovy
Mounjaro
As Lilly surges, headwinds against its weight loss drugs are growing
Pharma Voice
Wed, 05/15/24 - 11:18 am
Eli Lilly
Mounjaro
drug pricing
earnings
Big Pharma’s most improved drugs: a new generation of blockbusters
Pharma Voice
Tue, 05/14/24 - 11:34 am
Big Pharma
Eli Lilly
Mounjaro
Novo Nordisk
Wegovy
JNJ
Tecvayli
Merck
Vaxneuvance
AbbVie
Qulipta
AstraZeneca
Saphnelo
Novartis
Leqvio
Roche
Genentech
Vabysmo
Amgen
Evenity
Pfizer
Vyndaqel
How Lilly is using its Mounjaro millions to position as biotechs’ ‘partner of choice’
Fierce Biotech
Wed, 05/1/24 - 10:55 am
Eli Lilly
Gateway Labs
incubators
Mounjaro
biotech
Pages
1
2
3
4
5
next ›
last »